Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...

Trump’s pause in USAID spending has put major African HIV vaccine and prevention trials on hold, leaving the research world ...

Updated Hep B Vaccine More Effective for People With HIV ... 2024 — A new study reveals significant progress in the global fight against HIV/AIDS, alongside a stark warning that current trends ...

Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...

The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...

According to a post on USAID Southern Africa’s Facebook page, they have already invested around R1.7 billion in TB programmes ...

But there is no cure for HIV or AIDS or a vaccine for human use to prevent infection. One of the labs involved in current research to design such a vaccine is at La Jolla-based Scripps Research, which ...

Trump’s aid cut has also hit clinical trials. The South African Medical Research Council, which was awarded $45 million to ...

But there is no cure for HIV or AIDS or a vaccine for human use to prevent infection. One of the labs involved in current research to design such a vaccine is at La Jolla-based Scripps Research ...

Because South Africa has the world's largest population of people living with HIV, at more than 8 million, it is a hub for research on the virus. "Most of the landmark and groundbreaking studies have ...

The U.S. State Department said on Saturday that the President's Emergency Plan for AIDS Relief (PEPFAR) — the world's leading ...